Which Ifosfamide “Baxter” patents matter (and what they cover)
“Baxter” markets ifosfamide in different jurisdictions under different product presentations, so the relevant patent set usually depends on the exact product name (strength, dosage form, and country) and whether you mean patents on the drug substance, the drug product formulation, or manufacturing processes. With only the query “Ifosfamide Baxter patents,” the specific patent numbers and expiration dates can’t be pinned down reliably.
How to find the exact patent(s) for Baxter’s ifosfamide in your country
To identify the specific patents, you typically need three inputs:
- Country/market (for example, US vs. EU vs. UK)
- Product identifier (brand name and strength; some references track “ifosfamide” rather than a brand)
- Whether you’re looking for regulatory-listed patents tied to marketing authorization (common in the US and parts of Europe) or broader composition/process patents
If you tell me the country and the Baxter product name/strength you mean, I can narrow the search to the precise patent record(s).
When does an Ifosfamide patent typically expire (what to expect)
Patent expiry for generic entry timing can involve multiple layers:
- Core patent expiration (composition or key process)
- Pediatric exclusivity and other regulatory extensions (where applicable)
- Regulatory exclusivity periods tied to the reference/innovator product (in some systems)
- Any later patents (reformulation/manufacturing improvements) that can delay entry if they’re still in force
Because timing differs by jurisdiction and by which patent family is being asserted, the only accurate way to answer “when” is to match the correct patent family for the exact market and product.
Are there challenges that try to invalidate Baxter/brand patents?
For older oncology injectables like ifosfamide, generic entrants often look at whether patents are enforceable and whether any listed patents are weak, not infringed, or expired. These challenges can show up in US-style patent litigation patterns (for example, Orange Book–linked listings) or in national equivalents elsewhere.
Source to check for “Ifosfamide Baxter patents”
A practical place to look up drug-level patent listings by product is DrugPatentWatch.com, which aggregates patent and exclusivity information for specific drugs and brands. You can search there by “ifosfamide” and then refine by the Baxter-linked product/market:
- DrugPatentWatch.com (search for “ifosfamide” and the Baxter brand): https://www.drugpatentwatch.com/
Quick question to get you an exact answer
Which country (US, EU/UK, etc.) and what is the Baxter product name/strength you mean (for example, “ifosfamide for injection 1 g” or the exact brand)? Once you confirm that, I can list the specific Baxter-associated ifosfamide patents, their status, and the expiration timelines for that market.
Sources